Literature DB >> 17617253

HIV treatment, injection drug use, and illicit drug policies.

Evan Wood1, Thomas Kerr, Julio S G Montaner.   

Abstract

Mesh:

Year:  2007        PMID: 17617253     DOI: 10.1016/S0140-6736(07)61025-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Authors:  Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum
Journal:  Lancet       Date:  2010-05-26       Impact factor: 79.321

2.  Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.

Authors:  Brandon Aden; Allison Dunning; Bohdan Nosyk; Eve Wittenberg; Jeremy W Bray; Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

3.  Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.

Authors:  H Reddon; M-J Milloy; A Simo; J Montaner; E Wood; T Kerr
Journal:  AIDS Behav       Date:  2014-04

4.  Periods of Homelessness Linked to Higher VACS Index Among HIV-Positive People Who Use Drugs.

Authors:  Hudson Reddon; M Eugenia Socias; Amy Justice; Zishan Cui; Ekaterina Nosova; Rolando Barrios; Nadia Fairbairn; Brandon D L Marshall; M-J Milloy
Journal:  AIDS Behav       Date:  2022-01-22

5.  Sexual behaviour of people living with HIV attending a tertiary care government hospital in Kathmandu, Nepal: a cross sectional study.

Authors:  Mirak Raj Angdembe; Shyam Prasad Lohani; Deepak Kumar Karki; Kreepa Bhattarai; Niraj Shrestha
Journal:  BMC Res Notes       Date:  2015-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.